Table 1.
Organ donor ID |
Age (years) |
Sex | T1D duration (years) |
Donor HLA | T cell | Autoantigen | HLA restriction | Reference |
---|---|---|---|---|---|---|---|---|
Donor A | 19 | M | 3 | A1, A2 | 8 CD4+ T cell clones | Proinsulin42–50 | DQ8 | [74••] |
B8, B51 | 1 CD4+ T cell clone | Proinsulin41–51 | DQ8 | [74••] | ||||
DR3, DR4 | 1 CD4+ T cell clone | Proinsulin41–49 | DQ8 | [74••] | ||||
DQ2, DQ8 | 1 CD4+ T cell clone | Proinsulin50–59 | DQ8 | [74••] | ||||
1 CD4+ T cell clone | Proinsulin50–58 | DQ8 | [74••] | |||||
2 CD4+ T cell clones | Proinsulin52–62 | DQ8transa | [74••] | |||||
1 CD4+ T cell clone | HIP C-peptide: IAPP2b | DQ8 | [75••] | |||||
1 CD4+ T cell clones | HIP C-peptide: IAPP2b | DQ8 | [75••] | |||||
nPOD6342 | 14 | F | 2 | A2, A68 | 1 CD4+ T-cell clone | GAD274–286 | DR4c | [76••] |
DR1, DR4 DQ5, DQ8 | 1 CD4+ Transductant (GSE.20D11)d | Insulin B9–23 | DQ8 | [77••] | ||||
nPOD6367 | 24 | M | 2 | A2, A29 DR4, DR7 DQ2, DQ8 | 1 CD4+ T cell line | HIP C-peptide:A-chainb | ND | [76••] |
nPOD6268 | 12 | F | 3 | A2, A68 DR17, DR13 DQ2, DQ6 | 3 CD8+ T cell lines | Pooled insulin B10–18, IA-2797–805, IGRP265–273 tetramers | A*02:01 | [76••] |
nPOD69 | 6 | F | 3 | A2, A26 | 1 CD4+ T cell line | Proinsulin76–90e | DR4c | [76••] |
DR4, DR7 | 1 CD4+ T cell line | Chromogranin Af | ND | [76••] | ||||
DQ2, DQ8 | 2 CD4+ T cell lines | Proinsulinf | ND | [76••] | ||||
nPOD6323 | 22 | F | 6 | A1, A25 | 1 CD4+ T cell line | Chromogranin Af | ND | [76••] |
DR4, DR17 | 1 CD4+ T cell line | HIP C-peptide:IAPP1b | ND | [76••] | ||||
DQ2, DQ8 | 1 CD4+ T cell line | HIP C-peptide: IAPP2b | ND | [76••] | ||||
1 CD4+ T cell line | GRP78292–305(Arg-Cit 297) | ND | [76••] | |||||
1 CD4+ Transductant (GSE.8E3)d | Proinsulin49–65 | DQ8transa | [77••] | |||||
1 CD4+ Transductant (GSE.6H9)d | Insulin B9–23 | DQ8 | [77••] | |||||
T1D.6 | 20 | M | 7 | A2, − | 1 CD4+ T cell line | GAD555–567 | DR4c | [76••] |
DR17, DR4 Q2, DQ8 | 1 CD4+ T cell line | HIP C-peptide:NP-Yb | DQ8 | [75••, 76••] | ||||
T1D.7 | 27 | M | 17 | A1, A3 | 1 CD4+ T cell clone | IAPP65–84(Arg-Cit 73, 81) | ND | [76••] |
DR17, DR4 | 1 CD4+ T cell clone | GAD115–127 | ND | [76••] | ||||
DQ2, DQ8 | 1 CD4+ T cell clone | IA-2545–562(Gln-Glu 548, 551, 556) | ND | [76••] |
The age, gender, HLA, and duration of T1D of the islet donors are shown along with the original citations. In this on-going project, these are the autoreactivities of islet-infiltrating T cell lines or clones identified, to date, and the donors from which the islet-infiltrating T cells were derived. (Adapted from: Babon JA, et al. Nat Med. 2016;22:1482–1487) [76••]
ND not determined
HLA-DQ8trans: DQA1*05:01/DQB1*03:02
HIP hybrid insulin peptide: fusion of a human insulin C-peptide fragment (N-terminus ELGGG) with a fragment of another peptide (A-chain insulin A-chain fragment, IAPP1 and 2 two islet amyloid polypeptide fragments, NP-Y neuropeptide Y fragment)
HLA-DR4 were all HLA-DRB1*04:01
Clonal CD4+ T-cell receptor transductant
Proinsulin76–90 (SLQPLALEGSLQKRG) is designated Proinsulin52–66 by numbering starting with the B chain
Epitopes not identified